MedTrace Logo

Development of a Novel Methodology Using BMVC Staining as an Assistance to Cancer Cytological Diagnosis

NCT01301690 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2011-09-19

No results posted yet for this study

Summary

3,6-bis(1-methyl-4-vinylpyridinium) carbazole diiodide (BMVC) is an inorganic chemical compound (Figure1). The uptake of BMVC in cancer cells and normal cells are different. Recently, a simple handheld device (Figure1) based on the fluorescence analysis of stained cells was established to instantly differentiate cancer cells from normal cells. The investigators want to quantitatively measure the fluorescence expression of BMVC in normal and cancer cells and explore the usefulness of this staining in head and neck lumps.

Conditions

  • Neck Mass

Sponsors & Collaborators

  • Far Eastern Memorial Hospital

    lead OTHER

Principal Investigators

  • Li-Jen Liao, MD · Department of Otolaryngology Far Eastern Memorial Hospital, Taipei, Taiwan

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01301690 on ClinicalTrials.gov